Which Is the True Role of Bridging Therapies for HCC Patients Waiting for Liver Transplantation?

Lai, Quirino; Vitale, Alessandro; Rossi, Massimo; Cillo, Umberto; Lerut, Jan; European Hepatocellular Cancer Liver Transplantation (EurHeCaLT) Study Group

doi:10.1097/SLA.0000000000002575

Which Is the True Role of Bridging Therapies for HCC Patients Waiting for Liver Transplantation?

Lai, Quirino

;

Vitale, Alessandro

;

Rossi, Massimo

;

Cillo, Umberto

;

European Hepatocellular Cancer Liver Transplantation (EurHeCaLT) Study Group

;et.al.

Files

Lai-2018-Whichisthetrueroleofbridging.pdf

Open Access
Adobe PDF
97.76 KB

Download

Details

Authors

Lai, Quirino
author
Vitale, Alessandro
author
Rossi, Massimo
author
Cillo, Umberto
author
Lerut, JanUCLouvain
author
European Hepatocellular Cancer Liver Transplantation (EurHeCaLT) Study Group
collaborator

Affiliations

UCLouvainSSS/IREC/CHEX - Pôle de chirgurgie expérimentale et transplantation
UCLouvain(SLuc) Service de chirurgie et transplantation abdominale

Citations

APA
Chicago
FWB

Lai, Q., Vitale, A., Rossi, M., Cillo, U., & Lerut, J. (2018). Which Is the True Role of Bridging Therapies for HCC Patients Waiting for Liver Transplantation? Annals of Surgery, 268(6), e56-e57. https://doi.org/10.1097/SLA.0000000000002575 (Original work published 2018)